FEXOFENADINE HYDROCHLORIDE TABLETS

FEXOFENADINE HYDROCHLORIDE TABLETS was reported 256 times

FEXOFENADINE HYDROCHLORIDE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BEZOLD ABSCESS 1 0.1429
1 PYLOROSPASM 1 0.0455
2 ARTERIAL STENOSIS LIMB 1 0.0196
3 ELEPHANTIASIS 1 0.0149
4 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
5 LUDWIG ANGINA 1 0.0069
6 SOCIOECONOMIC PRECARITY 1 0.0058
7 PROCEDURAL HYPERTENSION 1 0.0053
8 DEAFNESS PERMANENT 1 0.0051
9 GLOMERULONEPHRITIS ACUTE 1 0.0049
10 PERIPHERAL NERVE OPERATION 1 0.0046
11 VAGINAL MYCOSIS 1 0.0043
12 INFESTATION 1 0.0039
13 PANCREATIC INJURY 1 0.0033
14 CAUSTIC INJURY 1 0.0032
15 OESOPHAGEAL ACHALASIA 2 0.0031
16 EAR OPERATION 1 0.0027
17 MESOTHELIOMA MALIGNANT 1 0.0027
18 VERTEBRAL OSTEOPHYTE 1 0.0023
19 VULVOVAGINAL RASH 1 0.0023
20 TUMOUR INVASION 1 0.0021
21 BLEPHARAL PIGMENTATION 1 0.0020
22 FAECAL VOLUME INCREASED 1 0.0019
23 SCAPULA FRACTURE 1 0.0019
24 RETROPERITONEAL LYMPHADENOPATHY 1 0.0019
25 INSTILLATION SITE REACTION 2 0.0018
26 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
27 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
28 SACRAL PAIN 1 0.0016
29 MITRAL VALVE CALCIFICATION 1 0.0016
30 HYPOTRICHOSIS 1 0.0016
31 INJECTION SITE EXFOLIATION 1 0.0015
32 BORDERLINE PERSONALITY DISORDER 1 0.0014
33 TONGUE PARALYSIS 1 0.0014
34 WITHDRAWAL BLEED 1 0.0014
35 BACTERIAL DISEASE CARRIER 1 0.0014
36 ASPIRATION PLEURAL CAVITY 1 0.0013
37 ENDOCARDITIS BACTERIAL 1 0.0013
38 OCULAR VASCULAR DISORDER 1 0.0012
39 ADRENAL MASS 1 0.0012
40 BILIARY DYSKINESIA 2 0.0012
41 ABDOMINAL LYMPHADENOPATHY 1 0.0012
42 ENDOCRINE OPHTHALMOPATHY 1 0.0012
43 OESOPHAGEAL OBSTRUCTION 1 0.0012
44 FOLLICULAR LYMPHOMA 1 0.0011
45 ABDOMINAL SEPSIS 1 0.0011
46 MUSCLE CRAMP 2 0.0011
47 LIGAMENT DISORDER 1 0.0011
48 LIPOATROPHY 1 0.0011
49 DUODENAL PERFORATION 1 0.0010
50 SKIN OEDEMA 1 0.0010
51 ONYCHALGIA 1 0.0010
52 RENAL MASS 2 0.0010
53 NASAL INFLAMMATION 1 0.0009
54 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
55 NAIL GROWTH ABNORMAL 1 0.0009
56 DILATATION ATRIAL 1 0.0009
57 INFREQUENT BOWEL MOVEMENTS 2 0.0008
58 AUDITORY DISORDER 1 0.0007
59 SEBORRHOEIC KERATOSIS 1 0.0007
60 REBOUND ACID HYPERSECRETION 2 0.0007
61 NEPHROGENIC ANAEMIA 3 0.0006
62 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
63 TINEA PEDIS 1 0.0006
64 OROPHARYNGEAL BLISTERING 1 0.0006
65 EROSIVE OESOPHAGITIS 1 0.0006
66 CAROTID ARTERY STENOSIS 2 0.0006
67 DRUG SCREEN NEGATIVE 1 0.0006
68 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
69 MOTION SICKNESS 1 0.0005
70 VOCAL CORD DISORDER 1 0.0005
71 PHYSICAL ASSAULT 1 0.0005
72 BODY HEIGHT DECREASED 5 0.0005
73 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
74 DANDRUFF 1 0.0005
75 GASTROINTESTINAL ULCER 1 0.0005
76 FEAR OF DEATH 1 0.0004
77 CYTOMEGALOVIRUS COLITIS 1 0.0004
78 BREAKTHROUGH PAIN 1 0.0004
79 PUSTULE 1 0.0004
80 INSTILLATION SITE PAIN 1 0.0004
81 HYPERPARATHYROIDISM SECONDARY 1 0.0004
82 VENTRICULAR HYPERTROPHY 1 0.0004
83 RETINAL ARTERY OCCLUSION 1 0.0004
84 BLOOD POTASSIUM ABNORMAL 1 0.0004
85 TRICHORRHEXIS 1 0.0004
86 JOINT LOCK 1 0.0004
87 IMPAIRED DRIVING ABILITY 4 0.0004
88 TUMOUR HAEMORRHAGE 1 0.0004
89 PHARYNGEAL DISORDER 1 0.0003
90 DYSCHEZIA 1 0.0003
91 MEDICAL DEVICE DISCOMFORT 1 0.0003
92 MASTICATION DISORDER 1 0.0003
93 EYELIDS PRURITUS 1 0.0003
94 PRE-EXISTING CONDITION IMPROVED 2 0.0003
95 CARDIAC FLUTTER 2 0.0003
96 DEAFNESS NEUROSENSORY 1 0.0003
97 PRODUCT FORMULATION ISSUE 2 0.0003
98 WOUND DEHISCENCE 1 0.0003
99 ULCER HAEMORRHAGE 2 0.0003
100 HANGOVER 1 0.0003
101 THERMAL BURN 2 0.0003
102 SKIN WEEPING 1 0.0003
103 AMYLASE INCREASED 1 0.0003
104 FREEZING PHENOMENON 1 0.0003
105 ORAL INFECTION 1 0.0003
106 WOUND SECRETION 1 0.0003
107 PROSTATOMEGALY 1 0.0003
108 AZOTAEMIA 1 0.0003
109 FOREIGN BODY 1 0.0002
110 SPINAL COMPRESSION FRACTURE 2 0.0002
111 SOCIAL PROBLEM 1 0.0002
112 THYROID FUNCTION TEST ABNORMAL 1 0.0002
113 SLEEP TERROR 1 0.0002
114 TONGUE DISCOMFORT 1 0.0002
115 PURULENT DISCHARGE 1 0.0002
116 HORDEOLUM 1 0.0002
117 CHAPPED LIPS 1 0.0002
118 ONYCHOMYCOSIS 1 0.0002
119 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
120 EXOSTOSIS 2 0.0002
121 ARTHRITIS INFECTIVE 1 0.0002
122 GASTRITIS EROSIVE 1 0.0002
123 BLOOD PROLACTIN INCREASED 1 0.0002
124 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
125 VULVOVAGINAL PAIN 1 0.0002
126 PROTEIN URINE PRESENT 1 0.0002
127 HEPATIC ENZYME ABNORMAL 1 0.0002
128 VEIN DISORDER 1 0.0002
129 CORONARY ARTERY STENOSIS 1 0.0002
130 VULVOVAGINAL PRURITUS 1 0.0002
131 SKIN NECROSIS 1 0.0002
132 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
133 OVERWEIGHT 1 0.0002
134 PRODUCT SIZE ISSUE 1 0.0002
135 ERYTHEMA OF EYELID 1 0.0002
136 BIPOLAR DISORDER 2 0.0002
137 ASTHENOPIA 1 0.0002
138 STREPTOCOCCAL INFECTION 1 0.0002
139 NECROSIS 1 0.0002
140 INTRACRANIAL PRESSURE INCREASED 1 0.0002
141 MITRAL VALVE INCOMPETENCE 2 0.0002
142 CHOLECYSTECTOMY 2 0.0002
143 HYPERVENTILATION 1 0.0002
144 METABOLIC DISORDER 1 0.0002
145 PRODUCT LABEL CONFUSION 1 0.0002
146 SINUS HEADACHE 1 0.0002
147 PROTHROMBIN TIME PROLONGED 1 0.0002
148 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
149 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
150 INJECTION SITE VESICLES 1 0.0002
151 FOREIGN BODY SENSATION IN EYES 1 0.0002
152 POOR QUALITY DRUG ADMINISTERED 1 0.0002
153 TENDON DISORDER 1 0.0002
154 POLYP 1 0.0002
155 WALKING AID USER 1 0.0002
156 SKIN MASS 1 0.0001
157 CHOLECYSTITIS CHRONIC 1 0.0001
158 IMPAIRED GASTRIC EMPTYING 2 0.0001
159 BLOOD TESTOSTERONE DECREASED 1 0.0001
160 INFARCTION 1 0.0001
161 CHRONIC KIDNEY DISEASE 11 0.0001
162 HAIR GROWTH ABNORMAL 1 0.0001
163 LARGE INTESTINE PERFORATION 1 0.0001
164 HUNGER 2 0.0001
165 EXTRASYSTOLES 1 0.0001
166 DEFAECATION URGENCY 1 0.0001
167 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
168 APPLICATION SITE REACTION 1 0.0001
169 PRODUCT SUPPLY ISSUE 1 0.0001
170 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
171 POOR QUALITY SLEEP 3 0.0001
172 DERMATITIS BULLOUS 1 0.0001
173 SKIN HAEMORRHAGE 2 0.0001
174 HAIR DISORDER 1 0.0001
175 EYE PRURITUS 4 0.0001
176 PARANOIA 2 0.0001
177 NAIL DISORDER 1 0.0001
178 RESPIRATORY RATE INCREASED 1 0.0001
179 END STAGE RENAL DISEASE 2 0.0001
180 PNEUMONIA BACTERIAL 1 0.0001
181 GRAND MAL CONVULSION 1 0.0001
182 BLOOD CHOLESTEROL INCREASED 5 0.0001
183 DIARRHOEA HAEMORRHAGIC 1 0.0001
184 FLANK PAIN 1 0.0001
185 HEPATIC CIRRHOSIS 2 0.0001
186 PHOTOPHOBIA 2 0.0001
187 ARTERIOSCLEROSIS 1 0.0001
188 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
189 EYE IRRITATION 6 0.0001
190 ACUTE RESPIRATORY FAILURE 2 0.0001
191 DIZZINESS POSTURAL 1 0.0001
192 PHARYNGEAL SWELLING 1 0.0001
193 LIGAMENT SPRAIN 1 0.0001
194 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
195 SPINAL FRACTURE 2 0.0001
196 THERAPY CESSATION 5 0.0001
197 SKELETAL INJURY 1 0.0001
198 HYPERBILIRUBINAEMIA 1 0.0001
199 EYE DISCHARGE 1 0.0001
200 IMPAIRED WORK ABILITY 2 0.0001
201 DECREASED ACTIVITY 1 0.0001
202 BLOOD GLUCOSE FLUCTUATION 1 0.0001
203 GASTROINTESTINAL PAIN 1 0.0001
204 EXPIRED PRODUCT ADMINISTERED 3 0.0001
205 FOOT DEFORMITY 1 0.0001
206 SNEEZING 2 0.0001
207 EYE INFECTION 1 0.0001
208 HEART RATE IRREGULAR 2 0.0001
209 APPLICATION SITE PRURITUS 2 0.0001
210 NEOPLASM 1 0.0001
211 MADAROSIS 1 0.0001
212 EYELID OEDEMA 1 0.0001
213 VASCULITIS 1 0.0001
214 MENTAL IMPAIRMENT 2 0.0001
215 BURSITIS 1 0.0001
216 SCHIZOPHRENIA 1 0.0001
217 INJECTION SITE EXTRAVASATION 1 0.0001
218 CYST 1 0.0001
219 ILEUS 1 0.0001
220 SECRETION DISCHARGE 1 0.0001
221 PRODUCT USE ISSUE 15 0.0001
222 INTESTINAL OBSTRUCTION 3 0.0001
223 INJECTION SITE IRRITATION 1 0.0001
224 HIATUS HERNIA 1 0.0001
225 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
226 APPLICATION SITE ERYTHEMA 2 0.0001
227 ORAL CANDIDIASIS 1 0.0001
228 RENAL FAILURE 10 0.0001
229 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
230 FEAR 2 0.0001
231 JAUNDICE 2 0.0001
232 EXTRA DOSE ADMINISTERED 3 0.0001
233 ORAL DISCOMFORT 1 0.0001
234 DIALYSIS 1 0.0001
235 IMPAIRED QUALITY OF LIFE 1 0.0001
236 PARAESTHESIA ORAL 1 0.0001
237 MYELODYSPLASTIC SYNDROME 1 0.0001
238 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
239 SEPTIC SHOCK 3 0.0001
240 URINARY INCONTINENCE 2 0.0001
241 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
242 THROAT IRRITATION 3 0.0001
243 HYPOAESTHESIA ORAL 1 0.0001
244 LACRIMATION INCREASED 2 0.0001
245 CORONARY ARTERY DISEASE 2 0.0001
246 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
247 DEVICE FAILURE 1 0.0001
248 ACUTE KIDNEY INJURY 10 0.0001
249 HIP ARTHROPLASTY 1 0.0001
250 MUSCULOSKELETAL CHEST PAIN 1 0.0001
251 DELUSION 1 0.0001
252 EJECTION FRACTION DECREASED 1 0.0001
253 MOVEMENT DISORDER 2 0.0001
254 BLOOD POTASSIUM INCREASED 1 0.0001
255 IMPAIRED HEALING 2 0.0001
256 MANIA 1 0.0001
257 SKIN DISORDER 2 0.0001
258 HEMIPARESIS 1 0.0001
259 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
260 MULTI-ORGAN FAILURE 1 0.0001
261 DEVICE DEFECTIVE 1 0.0001
262 MUSCULOSKELETAL PAIN 3 0.0001
263 INTENTIONAL PRODUCT MISUSE 5 0.0001
264 HEART RATE DECREASED 2 0.0001
265 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
266 GALLBLADDER DISORDER 1 0.0001
267 GOUT 1 0.0001
268 TOOTHACHE 1 0.0001
269 DRUG EFFECT INCOMPLETE 2 0.0001
270 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
271 DYSGEUSIA 4 0.0001
272 DYSPNOEA EXERTIONAL 2 0.0001
273 FLATULENCE 3 0.0001
274 COLITIS 2 0.0001
275 BLOOD URINE PRESENT 1 0.0001
276 SLEEP APNOEA SYNDROME 1 0.0001
277 INCREASED APPETITE 1 0.0001
278 PULMONARY FIBROSIS 1 0.0001
279 CHOLESTASIS 1 0.0001
280 POST PROCEDURAL COMPLICATION 1 0.0001
281 DRUG PRESCRIBING ERROR 1 0.0001
282 ERUCTATION 1 0.0001
283 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
284 SINUS DISORDER 1 0.0001
285 CONSTIPATION 11 0.0001
286 PRODUCT PHYSICAL ISSUE 1 0.0000
287 PRODUCT ADMINISTRATION ERROR 1 0.0000
288 FEEDING DISORDER 1 0.0000
289 OSTEOPOROSIS 2 0.0000
290 RIB FRACTURE 1 0.0000
291 HYPERSENSITIVITY 9 0.0000
292 PERITONITIS 1 0.0000
293 PULMONARY HYPERTENSION 1 0.0000
294 DERMATITIS 1 0.0000
295 HALLUCINATION, VISUAL 1 0.0000
296 RENAL FAILURE ACUTE 2 0.0000
297 JOINT INJURY 1 0.0000
298 RECTAL HAEMORRHAGE 2 0.0000
299 APPLICATION SITE PAIN 1 0.0000
300 LIVER DISORDER 2 0.0000
301 STEVENS-JOHNSON SYNDROME 1 0.0000
302 GLOSSODYNIA 1 0.0000
303 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
304 MUSCULAR WEAKNESS 5 0.0000
305 ABDOMINAL PAIN UPPER 9 0.0000
306 TINNITUS 2 0.0000
307 MUSCLE TWITCHING 1 0.0000
308 PERICARDIAL EFFUSION 1 0.0000
309 COGNITIVE DISORDER 2 0.0000
310 INJURY 3 0.0000
311 SLEEP DISORDER 3 0.0000
312 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
313 DISEASE RECURRENCE 2 0.0000
314 BLOOD PRESSURE FLUCTUATION 1 0.0000
315 DIABETIC KETOACIDOSIS 1 0.0000
316 ENCEPHALOPATHY 1 0.0000
317 ABASIA 1 0.0000
318 WEIGHT INCREASED 9 0.0000
319 PNEUMONIA ASPIRATION 1 0.0000
320 CELLULITIS 2 0.0000
321 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
322 DEPRESSION 9 0.0000
323 ABDOMINAL PAIN LOWER 1 0.0000
324 GASTRIC CANCER 1 0.0000
325 PRODUCT COMPLAINT 1 0.0000
326 HAEMATEMESIS 1 0.0000
327 ANXIETY 11 0.0000
328 HAEMATOMA 1 0.0000
329 NERVOUSNESS 2 0.0000
330 GASTRITIS 1 0.0000
331 EAR INFECTION 1 0.0000
332 BREAST CANCER FEMALE 1 0.0000
333 MENSTRUATION IRREGULAR 1 0.0000
334 BLOOD BILIRUBIN INCREASED 1 0.0000
335 DRY MOUTH 3 0.0000
336 LIMB INJURY 1 0.0000
337 PALLOR 1 0.0000
338 DRUG DOSE OMISSION 6 0.0000
339 RESPIRATORY DISTRESS 1 0.0000
340 ABNORMAL DREAMS 1 0.0000
341 PROCEDURAL PAIN 1 0.0000
342 NECK PAIN 2 0.0000
343 ABDOMINAL DISCOMFORT 6 0.0000
344 LETHARGY 2 0.0000
345 PRODUCT SUBSTITUTION ISSUE 2 0.0000
346 DYSSTASIA 1 0.0000
347 MUSCULOSKELETAL STIFFNESS 3 0.0000
348 PALPITATIONS 4 0.0000
349 ASCITES 1 0.0000
350 CATARACT 2 0.0000
351 RESPIRATORY DISORDER 1 0.0000
352 IRRITABILITY 2 0.0000
353 PLEURAL EFFUSION 2 0.0000
354 BLOOD PRESSURE INCREASED 5 0.0000
355 EMOTIONAL DISORDER 1 0.0000
356 GYNAECOMASTIA 1 0.0000
357 NERVOUS SYSTEM DISORDER 1 0.0000
358 HEAD INJURY 1 0.0000
359 HYPOTHYROIDISM 1 0.0000
360 HIP FRACTURE 1 0.0000
361 PAIN IN EXTREMITY 9 0.0000
362 DYSPEPSIA 3 0.0000
363 EYE DISORDER 1 0.0000
364 HEART RATE INCREASED 3 0.0000
365 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
366 VISUAL ACUITY REDUCED 1 0.0000
367 FALL 10 0.0000
368 LIP SWELLING 1 0.0000
369 FUNGAL INFECTION 1 0.0000
370 GAIT INABILITY 1 0.0000
371 TYPE 2 DIABETES MELLITUS 1 0.0000
372 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
373 PRODUCT QUALITY ISSUE 4 0.0000
374 HEPATIC ENZYME INCREASED 2 0.0000
375 GASTRIC DISORDER 1 0.0000
376 VISION BLURRED 4 0.0000
377 ABDOMINAL DISTENSION 3 0.0000
378 WEIGHT DECREASED 8 0.0000
379 COUGH 8 0.0000
380 BURNING SENSATION 2 0.0000
381 HYPERKALAEMIA 1 0.0000
382 HYPERTENSION 6 0.0000
383 CRYING 1 0.0000
384 RESTLESSNESS 1 0.0000
385 MUSCLE SPASMS 5 0.0000
386 DYSURIA 1 0.0000
387 INJECTION SITE MASS 1 0.0000
388 EYE SWELLING 1 0.0000
389 HEPATIC FUNCTION ABNORMAL 1 0.0000
390 EPISTAXIS 2 0.0000
391 INSOMNIA 7 0.0000
392 INJECTION SITE SWELLING 2 0.0000
393 DIZZINESS 13 0.0000
394 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
395 BACK PAIN 6 0.0000
396 ABDOMINAL PAIN 6 0.0000
397 ARTHRITIS 2 0.0000
398 ABNORMAL BEHAVIOUR 1 0.0000
399 DISORIENTATION 1 0.0000
400 CARDIAC FAILURE 2 0.0000
401 CARDIAC FAILURE CONGESTIVE 2 0.0000
402 SOMNOLENCE 5 0.0000
403 DYSPNOEA 14 0.0000
404 OEDEMA PERIPHERAL 3 0.0000
405 BLINDNESS 1 0.0000
406 NEUTROPHIL COUNT DECREASED 1 0.0000
407 INFLUENZA LIKE ILLNESS 2 0.0000
408 INJECTION SITE ERYTHEMA 3 0.0000
409 ARTHRALGIA 10 0.0000
410 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
411 CARDIO-RESPIRATORY ARREST 1 0.0000
412 ROAD TRAFFIC ACCIDENT 1 0.0000
413 URTICARIA 4 0.0000
414 LOSS OF CONSCIOUSNESS 3 0.0000
415 MENTAL DISORDER 1 0.0000
416 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
417 TACHYCARDIA 2 0.0000
418 DEHYDRATION 3 0.0000
419 ADVERSE DRUG REACTION 2 0.0000
420 SUICIDAL IDEATION 2 0.0000
421 NASOPHARYNGITIS 4 0.0000
422 HYPOKALAEMIA 1 0.0000
423 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
424 CARDIAC DISORDER 2 0.0000
425 SWELLING 2 0.0000
426 ARRHYTHMIA 1 0.0000
427 OCULAR HYPERAEMIA 1 0.0000
428 DYSPHAGIA 2 0.0000
429 PULMONARY EMBOLISM 2 0.0000
430 PRODUCTIVE COUGH 1 0.0000
431 MULTIPLE SCLEROSIS 1 0.0000
432 GAIT DISTURBANCE 4 0.0000
433 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
434 CONTUSION 2 0.0000
435 ATRIAL FIBRILLATION 2 0.0000
436 DRUG INEFFECTIVE 27 0.0000
437 ALOPECIA 4 0.0000
438 DRY EYE 1 0.0000
439 SYNCOPE 2 0.0000
440 FLUID RETENTION 1 0.0000
441 CHEST DISCOMFORT 2 0.0000
442 ILLNESS 2 0.0000
443 FATIGUE 15 0.0000
444 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
445 HEADACHE 12 0.0000
446 PANCREATITIS 1 0.0000
447 OEDEMA 1 0.0000
448 PRURITUS 7 0.0000
449 TREMOR 3 0.0000
450 ARTHROPATHY 1 0.0000
451 PAIN 11 0.0000
452 PANCYTOPENIA 1 0.0000
453 BLISTER 1 0.0000
454 HYPONATRAEMIA 1 0.0000
455 EYE PAIN 1 0.0000
456 CEREBROVASCULAR ACCIDENT 3 0.0000
457 INCORRECT DOSE ADMINISTERED 4 0.0000
458 MYOCARDIAL INFARCTION 3 0.0000
459 DYSPHONIA 1 0.0000
460 BONE PAIN 1 0.0000
461 NASAL CONGESTION 1 0.0000
462 EMOTIONAL DISTRESS 2 0.0000
463 THERAPEUTIC RESPONSE DECREASED 1 0.0000
464 DISCOMFORT 1 0.0000
465 CHEST PAIN 3 0.0000
466 ASTHENIA 6 0.0000
467 PNEUMONIA 5 0.0000
468 DEEP VEIN THROMBOSIS 1 0.0000
469 BLOOD PRESSURE DECREASED 1 0.0000
470 DRY SKIN 2 0.0000
471 NEOPLASM MALIGNANT 1 0.0000
472 HYPOTENSION 3 0.0000
473 VOMITING 7 0.0000
474 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
475 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
476 OVERDOSE 3 0.0000
477 NAUSEA 11 0.0000
478 INFECTION 2 0.0000
479 RASH 6 0.0000
480 UNDERDOSE 1 0.0000
481 MALAISE 6 0.0000
482 BRONCHITIS 1 0.0000
483 HYPOAESTHESIA 2 0.0000
484 HALLUCINATION 1 0.0000
485 HOT FLUSH 1 0.0000
486 UNEVALUABLE EVENT 1 0.0000
487 DIABETES MELLITUS 1 0.0000
488 DECREASED APPETITE 3 0.0000
489 PARAESTHESIA 2 0.0000
490 INJECTION SITE BRUISING 1 0.0000
491 INJECTION SITE HAEMORRHAGE 1 0.0000
492 FEELING ABNORMAL 3 0.0000
493 SKIN EXFOLIATION 1 0.0000
494 MYALGIA 2 0.0000
495 URINARY TRACT INFECTION 2 0.0000
496 PRODUCT STORAGE ERROR 1 0.0000
497 ADVERSE EVENT 1 0.0000
498 OROPHARYNGEAL PAIN 1 0.0000
499 BLOOD GLUCOSE INCREASED 2 0.0000
500 MIGRAINE 1 0.0000
501 CONDITION AGGRAVATED 3 0.0000
502 INJECTION SITE PAIN 3 0.0000
503 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
504 ERYTHEMA 2 0.0000
505 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
506 HAEMORRHAGE 1 0.0000
507 PLATELET COUNT DECREASED 1 0.0000
508 DIARRHOEA 6 0.0000
509 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
510 INFLUENZA 1 0.0000
511 SEPSIS 1 0.0000
512 RHEUMATOID ARTHRITIS 1 0.0000
513 SEIZURE 1 0.0000
514 CHILLS 1 0.0000
515 DISEASE PROGRESSION 1 0.0000
516 JOINT SWELLING 1 0.0000
517 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
518 VISUAL IMPAIRMENT 1 0.0000
519 OFF LABEL USE 7 0.0000
520 HYPERHIDROSIS 1 0.0000
521 PRODUCT DOSE OMISSION ISSUE 2 0.0000
522 PERIPHERAL SWELLING 1 0.0000
523 DRUG INTERACTION 1 0.0000
524 DRUG DEPENDENCE 1 0.0000
525 CONFUSIONAL STATE 1 0.0000
526 PYREXIA 2 0.0000
527 COVID-19 1 0.0000
528 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
529 NO ADVERSE EVENT 1 0.0000
530 ANAEMIA 1 0.0000